Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Back

ESC Premium Access

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Session: Anticoagulation in atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Doctor P. Noseworthy (Rochester, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)

3 presentations

0 follower

9 more presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Stockholm, SE)

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)

Access the full session

Anticoagulation in atrial fibrillation

Speakers: Doctor P. Noseworthy, Assistant Professor B. Hornestam, Associate Professor L. Friberg, Doctor P. Noseworthy, Mr J. Butt...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources